It’s the mighty Big Mac versus the new wave of GLP-1 weight-loss pills, and McDonald’s is getting ready for the challenge. While the fast-food giant hasn’t yet seen a major impact on its business from these medications, its leadership is closely watching the market and preparing for change.
“We don’t yet see evidence of it really having a material impact on our business,” said McDonald’s CEO Chris Kempczinski on a recent earnings call. However, he acknowledged that the recent approval of a pill form of the medication is seeing strong adoption, which is influencing the company’s testing strategies.
“As adoption grows, we know that consumers’ behavior changes,” Kempczinski added. “They eat fewer calories in the day, but also what they eat, the mix of that changes.” He pointed to protein as a key area of strength for the company, noting that customers using GLP-1 drugs remain very interested in it.
The landscape shifted last December when regulators approved a Wegovy pill from Novo Nordisk, which became available in pharmacies in January. A competing pill from Eli Lilly is also widely expected to hit the market soon. The introduction of these easier-to-use pills, coupled with efforts to lower prices, is anticipated to significantly increase the number of people using GLP-1 medications.
This potential shift has major food and beverage companies paying close attention. The CEO of a leading snack and beverage corporation noted that consumers are increasingly seeking smaller portions. “We see that consumers are continuing to engage in our categories, but in smaller portions,” he said. “That is a key strategic bet for us.”
McDonald’s is also monitoring changes in snacking habits and potential preferences for less-sugary beverages. Kempczinski confirmed that all these factors are being considered in the company’s current experiments and tests.
Despite the growing discussion around weight-loss drugs, McDonald’s recent quarterly performance was strong. The company reported better-than-expected earnings and sales, with a key sales metric rising 5.7%. Promotions and a returning value menu were credited with driving customer traffic. Nevertheless, some market analysts continue to flag the long-term economic pressures on franchisees and the potential risk of changing consumer habits as factors to watch.
